Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Look Back at Pirquet & Schick’s Influential Serum Sickness Study

Ruth Jessen Hickman, MD  |  Issue: November 2020  |  November 12, 2020

‘What first got me interested in serum sickness was the fact that lupus patients had similar manifestations,’ explains Dr. Atkinson. … ‘In the sickest lupus group, C3 & C4 are still used in almost every categorization I know of … .’

Theory of Serum Sickness

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In the final section, Pirquet and Schick pulled together research from the existing human and animal literature and speculated about disease pathophysiology. Confusing the issue, the clinical manifestations did not completely coincide with the presence of precipitins found in the serum, which made the role of antibodies unclear.7 However, they posited that the symptoms of serum sickness were created by a chemical reaction between the horse serum and the patient’s antibodies.

They proposed:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

We state the theory that there exists a causal connection between the formation of antibodies and [serum sickness].

As if to anticipate the resistance they were likely to receive, the two wrote:

The conception that the anti­bodies, which should protect against disease, are also responsible for the disease, sounds at first absurd. This has as its basis the fact that we are accustomed to see in disease only the harm done to the organisms and to see in the antibodies solely antitoxic substances.

They closed the monograph with a testament to their belief in the study’s worth and potential impact:

We believe to have shown that [serum sickness] has great importance, not only from a clinical viewpoint but also from the standpoint of general pathology: serum sickness is the best paradigma [sic] for a disease due to an organic cause which is unable to multiply, and is an exquisite object for the study of the changes going on in the system.

Follow-up & Response

Dr. Pirquet expanded on many of the ideas present in Die Serumkrankheit in his 1910 book, Allergy, written when he was a professor of pediatrics at Johns Hopkins. Here, Dr. Pirquet coined the term allergy (from the Greek roots “strange activity”).5 Since then, the term has taken on a more specific meaning, but then the distinction between allergy and immunity was not as clear.7

Dr. Silverstein explains, “In Allergy he tried to put together the observations that were known at the time, like skin reactions, the tuberculin reaction, serum sickness and anaphylaxis.” However, Dr. Silverstein notes that Dr. Pirquet did not think of himself as what we would call an allergist. He says, “There were no allergists at the time. People didn’t yet understand allergy and its basis.”

In Allergy, Dr. Pirquet made further observations, analyses and speculations about the pathogenesis of serum sickness. Here, he correctly identified immune complexes consisting of antigen and antibodies (“toxic bodies”) as the precipitating factor of the syndrome.5

Dr. Silverstein relates that for the most part, the importance of Die Serumkrankheit was not largely appreciated in the medical community. “It just wasn’t understood at the time, or it wasn’t paid attention to, because people were thinking of other things. So it didn’t really stimulate as one might have expected.”

Still, anti-sera treatments continued to be widely used over the next few decades. Although the pathophysiology of serum sickness was not yet proven, investigators during this time confirmed the clinical findings of Pirquet and Schick in several large retrospective studies of patients given such treatments.8,9 With the advent of antibiotics, far fewer people were given heterologous anti-sera. However, anti-sera treatments continued to be used in some applications, such as for the treatment of tetanus, rabies and botulism, and for snake and spider bites.10

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Conditions Tagged with:Lost & FoundSerum Sickness

Related Articles
    Dr. Yokoyama, MD, with Jennifer Laurent

    Interdisciplinary Collaboration at Wash U Advances Understanding of Immunology, Rheumatology

    October 14, 2015

    In June 2014, 10 members of a church group returned to St. Louis from Haiti, where they had contracted chikungunya virus (CHIKV), a mosquito-transmitted alphavirus previously unknown in the Western hemisphere that produces inflammatory arthritis symptoms. Because CHIKV-related arthritis mimics seronegative RA, a group of clinicians, immunologists, virologists and geneticists at the Washington University in…

    Rheumatologist John P. Atkinson, MD, Continues Research into Rare Diseases

    February 1, 2015

    At age 71, physician enjoys pursuing research into causes of human disease, drivers of inflammation

    2015 ACR/ARHP Annual Meeting: Cellular Triggers in Inflammatory Disease

    April 14, 2016

    SAN FRANCISCO—What factors help determine whether or not inflammation resolves, leading to healing, or becomes chronic, leading to disease and tissue destruction? A number of important cells, including toll-like receptors, mast cells, anti-citrullinated protein antibodies, complement and interferon, all play their own role in this process. By understanding how they act in innate and adaptive…

    The 2019 ACR Award Winners & Distinguished Fellows

    December 18, 2019

    ATLANTA—Every year at its Annual Meeting, the ACR recognizes its members’ outstanding contributions to the field of rheumatology through an awards program. The ACR is proud to announce 20 award recipients for 2019, honored for their accomplishments as clinicians, instructors or researchers who have helped advance rheumatology, for their commitment to inspire others to enter…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences